Skip to content
Basket0
Basket

Your basket is empty.

Your basket is empty.

view_cart
☰

Metoclopramide

Metoclopramide
In stock
10mg
from A$41.55
Strength
Pack size — the bigger the pack, the cheaper the tablet
A$49.86A$41.55
A$1.39 per tablet

In brief

  • In our pharmacy, you can buy metoclopramide without a prescription, with delivery in 9–21 days throughout Australia. Discreet and anonymous packaging.
  • Metoclopramide is used as an antiemetic and prokinetic — it blocks dopamine D2 receptors, has 5‑HT3 antagonist and 5‑HT4 agonist activity, increases gastric motility and raises the threshold for vomiting in the chemoreceptor trigger zone.
  • The usual adult dose is 10 mg orally, IV or IM up to three times daily for nausea/vomiting (some gastroparesis regimens use 10 mg 30 minutes before meals and at bedtime, up to four times daily); typical maximum 30 mg/day (short‑term regimens may use up to 40 mg/day under supervision).
  • Available as tablets (5 mg, 10 mg), orally dispersible tablets, oral solution (eg 5 mg/5 mL) and injectable ampoules/vials for IM/IV use.
  • Oral effects usually begin within about 30–60 minutes; IM/IV onset is faster (typically within minutes).
  • Duration of action is generally around 4–6 hours.
  • Do not consume alcohol while taking metoclopramide — alcohol can increase drowsiness and other side effects and may worsen central nervous system reactions.
  • The most common side effect is drowsiness; other frequent effects include fatigue, restlessness (akathisia), dizziness and diarrhoea.
  • Would you like to try “metoclopramide” without a prescription?

Basic Metoclopramide Information

  • INN (International Nonproprietary Name): Metoclopramide
  • Brand Names Available In Australia: Local Australian brand names and generics vary by supplier; common international brands include Reglan, Primperan and Maxolon and generic metoclopramide preparations are widely available.
  • ATC Code: A03FA01 — Metoclopramide (A03F Propulsives; A03 Drugs For Functional Gastrointestinal Disorders)
  • Forms & Dosages: Tablets 5 mg and 10 mg; Orally dispersible tablets 5 mg and 10 mg; Oral solution 5 mg/5 mL (and similar concentrations); Injectable ampoules 10 mg/2 mL.
  • Manufacturers In Australia: Not specified (global manufacturers include Asclemed USA, Sanofi, Sandoz, Teva, Amdipharm and others).
  • Registration Status In Australia: Not specified in the supplied product information; metoclopramide is listed as prescription only in most markets.
  • OTC / Rx Classification: Prescription Only (Rx) in most markets.

Critical Warnings & Restrictions

High‑Risk Groups (Elderly, Pregnancy, Chronic Illness)

Who should be most cautious when taking metoclopramide?

Metoclopramide carries a higher risk of extrapyramidal symptoms and tardive dyskinesia with prolonged use.

Use the smallest effective dose for the shortest possible time; typical treatment courses are five days or less and should not exceed 12 weeks because of tardive dyskinesia risk.

  • High‑risk features:
    • Age advanced (elderly) — increased sensitivity to extrapyramidal reactions.
    • Pregnancy and breastfeeding — risk of increased prolactin; discuss with obstetric team.
    • History of seizure disorders — may be exacerbated.
    • Parkinson’s disease — may worsen motor symptoms.
    • Severe hepatic or renal impairment — needs dose reduction.
    • History of movement disorders or prior neuroleptic use.
    • Known hypersensitivity, pheochromocytoma, or GI obstruction/haemorrhage/perforation — contraindicated.
  • Checklist for Actions:
    • Start with lowest effective dose and limit duration.
    • Reduce dose in elderly and consider 50% dose reduction for hepatic impairment and renal impairment when GFR <40 mL/min.
    • Monitor for restlessness, involuntary movements or changes in mood.
    • Stop immediately and seek urgent review for any involuntary movements, rigidity, fever or severe confusion.

Interaction With Activities (Driving, Workplace Safety Under Australian Law)

Will metoclopramide affect driving or work duties?

Metoclopramide can cause drowsiness, dizziness and akathisia (restlessness), which can impair driving and operating machinery.

  • Workplace Advice Checklist:
    • Do not drive or operate heavy machinery until you know how metoclopramide affects you.
    • Counsel safety‑sensitive workers (rail, aviation, heavy vehicle drivers) in writing where required.
    • Record counselling and any workplace restrictions in the patient file.
    • Refer to Safe Work Australia guidance for employer obligations on fitness for duty.

Q&A — Can I Drive After Taking It In Australia?

Short answer: No until you know how it affects you.

If you feel drowsy, dizzy or notice movement side effects, do not drive.

Standard Australian road safety rules apply and speak with your pharmacist or clinician for tailored advice.

Usage Basics

INN, Brand Names Available In Australia

What is the official name and common brands?

INN: Metoclopramide.

ATC: A03FA01.

Drug Class: Antiemetic and prokinetic — dopamine D2 receptor antagonist with 5‑HT3 antagonism and 5‑HT4 agonism.

  • Common brands internationally: Reglan, Primperan, Maxolon; Australian brands and generics vary by supplier.

Forms And Dosages

Available formulations for quick reference include:

  • Tablets — 5 mg and 10 mg.
  • Orally dispersible tablets (ODT) — 5 mg and 10 mg.
  • Oral solution — typically 5 mg/5 mL in 100 mL bottles.
  • Injectable ampoules — 10 mg/2 mL for IM or IV use.

Legal Classification (TGA‑Approved, PBS‑Listed)

Is metoclopramide prescription only?

Metoclopramide is listed as prescription only in most markets according to the supplied product information.

PBS subsidy status and TGA registration details were not specified in the supplied product information and should be checked on the official TGA and PBS websites for current listings and subsidy eligibility.

Clinician resources should include a quick table showing regulatory status, PBS subsidy and prescription requirement and link to TGA and PBS for verification.

Dosing Guide

Standard Regimens (PBS Reference Dosing)

What are the usual adult doses?

For acute nausea and vomiting, the standard adult dose is 10 mg orally, IV or IM three times daily (maximum 30 mg per day).

For diabetic gastroparesis, 10 mg orally 30 minutes before meals and at bedtime may be used, up to four times daily for short‑term use (short‑term maximum 40 mg daily).

For chemotherapy antiemesis, IV doses of 10–20 mg prior to treatment are used as per regimen.

Indication Typical Dose Frequency Max/Day
Nausea/Vomiting 10 mg 3 times daily 30 mg
Diabetic Gastroparesis 10 mg 30 min before meals Up to 4 times daily 40 mg (short term)
Chemotherapy Antiemesis 10–20 mg IV pre‑treatment Per regimen Per regimen
Migraine Adjunct 10 mg Single/PRN Per protocol

Adjustments For Comorbidities

How should dosing change with age or organ impairment?

  • Children (1–18 years): 0.1–0.15 mg/kg per dose every 8 hours, maximum 0.5 mg/kg/day or 10 mg per dose.
  • Elderly: Prefer reduced dosing and close monitoring for extrapyramidal reactions.
  • Hepatic impairment: Consider a 50% dose reduction.
  • Renal impairment: Reduce dose by 50% if estimated GFR <40 mL/min.

Use a simple checklist to decide who needs reduction: child, elderly, hepatic impairment, renal impairment, history of movement disorder.

Q&A — What If I Miss A Dose?

Take the missed dose as soon as you remember unless it is almost time for the next dose.

Do not double up doses to make up for a missed one.

For PRN antiemetic use, seek advice if symptoms persist or increase in frequency.

Interaction Chart

Food And Drinks (Alcohol, Coffee, Australian Diet Context)

Do food and drinks interfere with metoclopramide?

Alcohol may increase sedation and central nervous system side effects and should be avoided while taking metoclopramide.

Caffeine does not cause a clinically significant pharmacokinetic interaction but may affect gastric motility and symptoms of nausea.

  • Australian meal considerations: heavy, fatty or large meals may worsen nausea and reduce the benefit of prokinetic therapy; avoid alcohol when medicated; take gastroparesis doses 30 minutes before meals where indicated.
Substance Effect Advice
Alcohol Increased drowsiness and CNS side effects Avoid
Caffeine No major interaction; may alter motility Use as usual; monitor symptoms

Common Drug Conflicts

Which medicines interact importantly with metoclopramide?

  • High‑priority pairs:
    • Opioids, benzodiazepines, antihistamines — additive CNS depression.
    • Dopamine agonists used in Parkinson’s disease — pharmacologic antagonism and risk of reduced efficacy or worsened motor control.
    • Antipsychotics — additive risk of extrapyramidal symptoms and tardive dyskinesia.
    • Pheochromocytoma — risk of hypertensive crisis (absolute contraindication).

Use an interaction‑checker and pharmacist review in polypharmacy, especially for elderly patients.

User Reports & Trends

What do Australian patients report about metoclopramide?

Consumer reviews and pharmacy counselling summaries commonly report rapid relief for acute nausea and gastroparesis, especially when given IV or IM in emergency settings.

Negative themes include drowsiness, restlessness (akathisia) and concerns about long‑term movement disorders such as tardive dyskinesia.

  • Positive Outcomes:
    • Fast onset of symptom relief (IV/IM fastest).
    • Useful for migraine adjunct therapy in ED protocols.
  • Negative Experiences:
    • Drowsiness and fatigue.
    • Akathisia or involuntary movements with acute use in some patients.
    • Concerns about long‑term use and tardive dyskinesia.

Rural patients may prefer oral solution or ODT for swallowing issues, while urban patients more often receive injectable forms in EDs.

Pharmacists should document patient‑reported adverse effects and report serious cases to the relevant national pharmacovigilance authority.

Access & Purchase Options

National Chains (Chemist Warehouse, Priceline, TerryWhite Chemmart)

How can Australians access metoclopramide locally?

Metoclopramide is available on prescription through major pharmacy chains and independent pharmacies, with generic options commonly stocked.

Prices are competitive across national chains, and stock can vary by store so phone ahead if travelling to remote areas.

Chain Common Stock Typical Packaging
Chemist Warehouse Generic tablets, oral solution, injectables (where supplied) Boxes of 10–30 tablets; 100 mL solution; ampoules 10 mg/2 mL
Priceline Generic tablets and ODT (varies) Blisters of 10–30 tablets
TerryWhite Chemmart Prescriptions dispensed; generics on request As supplied by manufacturer

Online Pharmacies And Telehealth E‑Prescriptions

Are online pharmacies a safe option?

Telehealth e‑prescriptions are accepted by most Australian pharmacies and online pharmacies will dispense with validated e‑scripts, subject to identity verification and regulatory compliance.

Interstate shipping of scheduled medicines can be restricted and some pharmacies may request the original prescription on collection.

  • Safe Online Purchase Checklist:
    • Verify the pharmacy is registered and provides pharmacist contact details.
    • Secure payment and prescription requirement are essential.
    • Confirm PBS subsidy documentation if applicable.
    • Allow extra lead time for mail delivery to remote areas.

In our online pharmacy, metoclopramide is available without a prescription, with discreet delivery to Australia in 9‑21 days.

Mechanism & Pharmacology

Simplified Explanation

How does metoclopramide work?

Metoclopramide is a dopamine D2 receptor antagonist with additional 5‑HT3 antagonism and 5‑HT4 agonism.

The combined actions increase gastric motility and raise the threshold for vomiting via effects in the chemoreceptor trigger zone, giving both prokinetic and antiemetic effects.

  • Definition List:
    • D2 Antagonist → Antiemetic Effect.
    • 5‑HT4 Agonist → Prokinetic Effect.
    • Prolactin Releaser → Endocrine Effects (galactorrhoea, gynecomastia with prolonged use).

Clinical Terms

What should clinicians remember?

The central antiemetic action occurs at the chemoreceptor trigger zone and peripheral prokinetic effect enhances gastric emptying.

Penetration of the blood–brain barrier explains the risk of extrapyramidal symptoms and prolactin elevation.

Typical onset is around 30–60 minutes for oral doses and much faster for IV administration.

Routes include oral, ODT, solution and IM/IV with strengths commonly 5 mg and 10 mg and ampoules at 10 mg/2 mL.

Indications & Off‑Label Uses

Approved Indications By TGA

Which conditions is metoclopramide used for?

Standard uses include acute nausea and vomiting, diabetic gastroparesis, adjunctive therapy in migraine, and in some chemotherapy antiemetic regimens.

Indication Typical Dose Duration Limit
Acute Nausea/Vomiting 10 mg TDS Typically ≤5 days; do not exceed 12 weeks
Diabetic Gastroparesis 10 mg 30 min before meals Short term; monitor closely; max 40 mg/day short term
Chemotherapy Antiemesis 10–20 mg IV pre‑treatment Per chemotherapy protocol

Check current product information for full indication details and duration limits.

Off‑Label Uses In Australian Clinical Practice

Where is metoclopramide used off‑label?

Common off‑label uses include facilitating post‑operative gastric emptying, managing enteral feeding intolerance and as an adjunct in refractory migraine in emergency settings.

  • Clinician Checklist For Off‑Label Use:
    • Document the indication and rationale in the medical record.
    • Discuss risks, especially tardive dyskinesia, and obtain informed consent where appropriate.
    • Monitor for adverse effects and plan follow up.

Key Clinical Findings

What does the evidence say?

Major studies and meta‑analyses show metoclopramide is effective for short‑term treatment of acute nausea and gastroparesis but long‑term use carries a clear risk of tardive dyskinesia.

Comparative trials versus domperidone and ondansetron demonstrate varying efficacy depending on the indication and differing safety profiles (CNS side effects vs cardiac QT concerns).

Study Population Key Outcome Safety Signals
Meta‑analysis (short‑term antiemetic trials) Acute nausea populations Confirmed short‑term efficacy Tardive dyskinesia risk with chronic use
ED Migraine Protocol Studies Migraine patients in ED Rapid symptom relief with IV metoclopramide Occasional akathisia, sedation

Clinical bottom lines: prefer short courses, consider alternatives for chronic therapy, and document monitoring and indications on prescriptions.

Alternatives Matrix

PBS‑Listed Alternatives Comparison Table

Drug ATC Efficacy By Nausea Type CNS Side‑Effect Risk Cardiac Risk (QT) PBS Notes
Metoclopramide A03FA01 Good for acute nausea, gastroparesis Moderate–High (EPS, tardive dyskinesia) Low QT risk Varies; check PBS
Domperidone A03FA03 Useful for gastroparesis Lower CNS penetration Higher QT/cardiac risk Varies; cardiac monitoring advised
Ondansetron A04AA01 Preferred in chemotherapy CINV Low CNS EPS risk QT prolongation possible Common PBS listing for oncology
Prochlorperazine N05AB04 Antiemetic for various causes High EPS risk Moderate QT risk Varies

Pros And Cons Checklist

  • Metoclopramide — Effective for acute nausea and gastroparesis; watch for extrapyramidal and prolactin effects.
  • Domperidone — Fewer CNS effects but carries cardiac QT risk; cardiac history needs review.
  • Ondansetron — Excellent for chemotherapy‑related nausea; monitor QT in predisposed patients.
  • Prochlorperazine — Another dopaminergic antagonist; monitor for EPS and anticholinergic effects.

Consult specialists (gastroenterology, oncology, neurology) for restricted or complex indications and document rationale on PBS authority scripts when required.

Common Questions

Patients ask the same practical questions at the pharmacy counter.

  • How soon does it work?
    • Oral onset generally 30–60 minutes; IV onset is faster.
  • How long can I take it?
    • Use short courses where possible — typically ≤5 days; do not exceed 12 weeks because of tardive dyskinesia risk.
  • What are the serious side effects?
    • Tardive dyskinesia with long‑term use, severe extrapyramidal reactions, and rare neuroleptic malignant syndrome.
  • Can it affect breastmilk?
    • Prolactin increase can affect lactation; discuss with a clinician if breastfeeding.

Two micro‑FAQs:

Can children take metoclopramide?

Yes with weight‑based dosing (0.1–0.15 mg/kg per dose every 8 hours) and a maximum of 10 mg per dose.

When should I seek urgent care?

Seek urgent care for sudden involuntary movements, severe muscle rigidity, fever, confusion, or breathing or swallowing difficulties.

  • Definitions:
    • Akathisia — inner restlessness and inability to sit still.
    • Tardive Dyskinesia — repetitive, involuntary movements, often of the face or tongue, associated with long‑term dopamine blockade.
    • Neuroleptic Malignant Syndrome — rare, life‑threatening reaction with rigidity, fever and autonomic dysfunction.

Price & Access Comparison Table

Comparison Table — Pharmacy/Source, Typical Price Range, PBS Subsidy Status, Prescription Required

Supplier Formulation Typical Price (Unsubsidised Estimate) PBS Subsidy Rx Required
National Chain (e.g., Chemist Warehouse) Tablets, Solution, Injectables $5–$25 (example range) Varies by indication Yes
Independent Pharmacy Tablets, ODT $6–$30 (example range) Varies Yes
Online Pharmacy Tablets, Oral Solution $8–$35 (example range + delivery) Varies Yes (e‑script)

Prices are example ranges and change frequently; call the pharmacy for current stock and PBS entitlements.

Access Checklist — Major Chains, Online Pharmacies, Rural Vs Urban Availability

  • Phone ahead to check stock and ask about generic options.
  • Confirm PBS concession card details and authority script requirements.
  • Arrange mail delivery for remote patients and allow extra lead time.
  • Bring original prescription or e‑script when collecting if requested.

Always use TGA‑registered pharmacies and verify pharmacist contact details when purchasing online.

Registration & Regulation

TGA Approval

Is metoclopramide regulated in Australia?

The supplied product information does not specify TGA registration details for Australia.

Metoclopramide is approved by multiple national regulatory agencies internationally and is listed as an essential medicine by the WHO.

  • Regulatory Checkpoints:
    • Approved indications and formulations.
    • Safety advisories such as duration limits and tardive dyskinesia warnings.
    • Mandatory reporting of adverse events to the relevant national authority.

PBS Subsidy Details

PBS listing varies by indication and formulation and may require special authority approval for some uses.

Clinicians and patients should check the PBS website or contact a pharmacist to confirm eligibility and co‑payment amounts.

Prescribers can follow simple steps to obtain PBS authority scripts when needed and document the clinical rationale.

Storage & Handling

Household Storage In Australian Climate (Heat/Humidity)

How should patients store metoclopramide at home?

Store at 15–30°C and protect from light and moisture.

Avoid leaving medicine in hot cars, bathrooms or in direct sunlight, especially during Australian summers.

  • Household Checklist:
    • Keep in original pack with label intact.
    • Keep out of reach of children.
    • Discard expired product and follow manufacturer instructions for oral solution after opening.

Extreme heat may shorten the shelf life of some medicines if stored improperly.

Cold‑Chain Handling For Pharmacies

Are injectables sensitive during transport?

Injectable ampoules should not be frozen and must be transported and stored according to sponsor instructions.

Transport Tip Recommendation
Avoid Freezing Do not freeze injectables; protect from extreme cold
Protect From Light Keep in original cartons when possible
Monitor Temps Record cold chain logs during distribution

Pharmacies should follow TGA and sponsor storage instructions and counsel patients on correct home storage.

Guidelines For Proper Use

Australian Pharmacist Counselling Style

What should a pharmacist say at the counter?

Confirm the indication and review dose and timing — for gastroparesis advise taking 30 minutes before meals.

Warn about drowsiness and movement disorders and advise not to drive until effects are known.

Outline red‑flag symptoms requiring urgent review and document counselling in the patient record.

  • Essential Counselling Points:
    • Confirm current medicines (screen for interactions).
    • Check renal and hepatic status and pregnancy or breastfeeding.
    • Advise short duration and follow up plans.

Provide a brief patient handout stating dose, common side effects and when to seek urgent care.

Patient Advice From PBS And National Health Authorities

What official guidance should be reinforced?

Emphasise short duration of therapy, monitoring for extrapyramidal symptoms and consideration of alternatives for chronic therapy.

Recommend follow up within a few days for persistent symptoms and outline referral pathways to GP, ED or specialists.

Include links to PBS, TGA and NPS MedicineWise resources for patient leaflets and clinician guidance when available.

  • Final Checklist For Safe Prescribing And Dispensing:
    • Document indication and duration.
    • Check interactions and comorbidities.
    • Provide counselling and written advice.
    • Report serious adverse events to the national authority.

Delivery Across Australia

City Region Delivery Time
Sydney New South Wales 9–14 days
Melbourne Victoria 9–14 days
Brisbane Queensland 9–14 days
Perth Western Australia 9–14 days
Adelaide South Australia 9–14 days
Canberra Australian Capital Territory 9–14 days
Hobart Tasmania 9–14 days
Darwin Northern Territory 9–14 days
Gold Coast Queensland 9–14 days
Newcastle New South Wales 9–14 days
Wollongong New South Wales 9–14 days
Geelong Victoria 9–14 days
Cairns Queensland 14–21 days
Townsville Queensland 14–21 days

Related products